Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion

Cavazzini Francesco; Lista Enrico; Quaglia Francesca Maria; Formigaro Luca; Cavallari Maurizio; Martinelli Sara; Rigolin Gian Matteo; Foa Robin; Cuneo Antonio

首页> 外文期刊>Leukemia and lymphoma >Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion

【24h】

Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion

机译：对难治性危及危及危及生命的自身免疫溶血性血栓溶性血栓溶性贫血的反应，其在翻倒的慢性淋巴细胞白血病患者中，具有17P缺失

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma》 |2016年第11期|共4页
作者
Cavazzini Francesco; Lista Enrico; Quaglia Francesca Maria; Formigaro Luca; Cavallari Maurizio; Martinelli Sara; Rigolin Gian Matteo; Foa Robin; Cuneo Antonio;
展开▼
作者单位

Univ Ferrara Dept Med Sci Sect Hematol Ferrara Italy;

Univ Ferrara Dept Med Sci Sect Hematol Ferrara Italy;

Univ Ferrara Dept Med Sci Sect Hematol Ferrara Italy;

Univ Ferrara Dept Med Sci Sect Hematol Ferrara Italy;

Univ Ferrara Dept Med Sci Sect Hematol Ferrara Italy;

Univ Ferrara Dept Med Sci Sect Hematol Ferrara Italy;

Univ Ferrara Dept Med Sci Sect Hematol Ferrara Italy;

Univ Roma La Sapienza Div Hematol Rome Italy;

Univ Ferrara Dept Med Sci Sect Hematol Ferrara Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion [J] . Cavazzini Francesco, Lista Enrico, Quaglia Francesca Maria, Leukemia and lymphoma . 2016,第11期

机译：复发的17p缺失慢性淋巴细胞白血病患者对难治性危及生命的自身免疫性溶血性贫血对依鲁替尼的反应
2. Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p) [J] . de Lacerda Marcelo Pitombeira, Guedes Nayara Ribeiro, Yamakawa Patricia Eiko, Annals of hematology . 2017,第9期

机译：用Del（17P）复发慢性淋巴细胞白血病耐霉菌自身免疫溶血性缺血性贫血
3. Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic?leukaemia treated with ibrutinib from 3 clinical trials [J] . Jones Jeffrey, Mato Anthony, Coutre Steven, British Journal of Haematology . 2018,第4期

机译：评价230例复发/难治缺失17P慢性淋巴细胞β白血病，伊布洛替尼治疗3临床试验
4. Efficiency and Toxmcity of the Fludarabine and Cyclo- Phosphamide Combined Therapy in Relapsed/ Resistant Patients with B-cell Chronic Lymphocytic Leukaemia (CLL)-Polish Multicenter Study [C] . M. Kowal, A. Dmoszynska, D. Jawniak, European Haematology Association . 2002

机译：B-Cell慢性淋巴细胞白血病（CLL） - 渗透多中心研究的复发/抗性患者复发/抗性患者的氟氮胺碱和环磷酰胺联合治疗的效率和毒性
5. Kinase Targeting Therapies in Chronic Lymphocytic Leukemia: Mechanisms of Acquired Ibrutinib Resistance and the Pre-Clinical Development of OSU-T315. [D] . Liu, Ta-Ming. 2014

机译：激酶靶向疗法在慢性淋巴细胞性白血病中：获得性依鲁替尼耐药性的机制和OSU-T315的临床前开发。
6. Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials [O] . Jeffrey Jones, Anthony Mato, Steven Coutre, -1

机译：依鲁替尼治疗3项临床试验对230例复发/难治性缺失17p慢性淋巴细胞白血病患者的评估
7. Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group [O] . Winqvist, Maria, Asklid, Anna, Andersson, P. O., 2016

机译：依鲁替尼在复发或难治性慢性淋巴细胞性白血病患者中的真实结果：来自以同情心使用计划治疗的95位连续患者的数据。瑞典慢性淋巴细胞白血病小组的一项研究

Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion

著录项

相似文献

相关主题

期刊订阅